VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
28 hedge funds and large institutions have $6.25M invested in Viracta Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
76% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 17
Holders
28
Holding in Top 10
1
Calls
$325K
Puts
$41K
Top Buyers
| 1 | +$1.83M | |
| 2 | +$188K | |
| 3 | +$41K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$20K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$18.1K |
Top Sellers
| 1 | -$331K | |
| 2 | -$145K | |
| 3 | -$38K | |
| 4 |
Jane Street
New York
|
-$36K |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$29K |